Document:

<Page>

                                                                   EXHIBIT 10.61

                                ESCROW AGREEMENT

     This ESCROW AGREEMENT (this "AGREEMENT") made as of May 31, 2005, by and
among BIO-KEY INTERNATIONAL, INC., (the "ISSUER"), JESUP & LAMONT SECURITIES
CORP. (the "PLACEMENT AGENT"), whose addresses and other information appear
below, and Thelen Reid & Priest LLP, 875 Third Avenue, New York, New York 10022
(the "ESCROW AGENT").

                                   WITNESSETH:

     WHEREAS, the Issuer proposes to sell $2.5-5 million (the "OFFERING AMOUNT")
of the Issuer's subordinated convertible debentures and warrants to purchase
common stock of the Issuer (the "SECURITIES") to investors (the subscribers of
the Securities pursuant to this offering are hereinafter referred to as
"INVESTORS"), in a private offering to accredited investors (the "OFFERING");

     WHEREAS, the Issuer and the Placement Agent propose to establish an escrow
account (the "ESCROW ACCOUNT"), to which subscription monies which are received
by the Escrow Agent from the Placement Agent in connection with the Offering are
to be credited, and the Escrow Agent is willing to establish the Escrow Account
on the terms and subject to the conditions hereinafter set forth;

     NOW, THEREFORE, in consideration of the premises and mutual covenants
herein contained, and intending to be legally bound hereby, the parties hereto
hereby agree as follows:

     2.   ESTABLISHMENT OF THE BANK ACCOUNT.

          2.1  The Escrow Agent shall use its IOLA account which is a
non-interest-bearing escrow account at the branch of a bank selected by the
Escrow Agent, (heretofore defined as the "BANK ACCOUNT"). The purpose of the
Bank Account is for (a) the deposit of all subscription monies (checks or wire
transfers) which are received by the Placement Agent from prospective purchasers
of the Securities and are delivered by the Placement Agent to the Escrow Agent,
(b) the holding of amounts of subscription monies which are collected through
the banking system and (c) the disbursement of collected funds, all as described
herein.

     3.   DEPOSITS TO THE BANK ACCOUNT.

          3.1  The Placement Agent shall promptly deliver to the Escrow Agent
all monies which it receives from prospective purchasers of the Securities,
which monies shall be in the form of wire transfers or checks, such monies, they
shall be credited to the Escrow Account. All checks delivered to the Escrow
Agent shall be made payable to "Thelen Reid & Priest LLP as Escrow Account." Any
check payable other than to the Escrow Agent as required hereby shall be
returned to the prospective purchaser, or if the Escrow Agent has insufficient
information to do so, then to the Placement Agent (together with any
Subscription Information, as defined below or other documents delivered
therewith) by noon of the next business day

<Page>

following receipt of such check by the Escrow Agent, and such check shall be
deemed not to have been delivered to the Escrow Agent pursuant to the terms of
this Agreement.

          3.2  Promptly after receiving subscription monies as described in
Section 3.1, the Escrow Agent shall deposit the same into the Bank Account.
Amounts of monies so deposited are hereinafter referred to as "ESCROW AMOUNTS".
Simultaneously with each deposit to the Escrow Account, the Placement Agent (or
the Issuer, if such deposit is made by the Issuer) shall inform the Escrow Agent
in writing of the name, address, and the tax identification number of the
purchaser, the aggregate dollar amount of such subscription (collectively, the
"SUBSCRIPTION INFORMATION").

          3.3  The Escrow Agent shall not be required to accept for credit to
the Escrow Account or for deposit into the Bank Account checks which are not
accompanied by the appropriate Subscription Information, which at minimum shall
include the name address and tax identification number. Wire transfers
representing payments by prospective purchasers shall not be deemed deposited in
the Escrow Account until the Escrow Agent has received in writing the
Subscription Information required with respect to such payments.

          3.4  The Escrow Agent shall not be required to accept in the Escrow
Account any amounts representing payments by prospective purchasers, whether by
check or wire, except during the Escrow Agent's regular business hours.

          3.5  Only those Escrow Amounts, which have been deposited in the Bank
Account and which have cleared the banking system and have been collected by the
Escrow Agent, are herein referred to as the "FUND."

          3.6  If the Offering is terminated before the Termination Date, as
defined below, the Escrow Agent shall refund any portion of the Fund prior to
disbursement of the Fund in accordance with Article 4 hereof upon instructions
in writing signed by both the Issuer and the Placement Agent. The parties hereto
acknowledge and agree that the Offering will not be effected until a binding
securities purchase agreement with respect to such Offering is duly executed and
delivered by the Issuer.

     4.   DISBURSEMENT FROM THE BANK ACCOUNT.

          4.1  Upon written instructions from the Issuer and the Placement Agent
the Escrow Agent shall release the Funds as directed in such instructions as
long as such instructions are received prior to the close of regular banking
hours on the Termination Date. After the Termination Date, unless extended by a
writing agreed to by all parties, the Escrow Agent shall promptly refund to each
prospective purchaser the amount of payment received from such purchaser which
is then held in the Fund or which thereafter clears the banking system, without
interest thereon or deduction there from, by drawing checks on the Bank Account
for the amounts of such payments and transmitting them to the purchasers. In
such event, the Escrow Agent shall promptly notify the Issuer and the Placement
Agent of its distribution of the Fund.

<Page>

          4.2 Upon disbursement of the Fund pursuant to the terms of this
Article 4, the Escrow Agent shall be relieved of further obligations and
released from all liability under this Agreement. It is expressly agreed and
understood that in no event shall the aggregate amount of payments made by the
Escrow Agent exceed the amount of the Fund.

     5.   RIGHTS,  DUTIES AND  RESPONSIBILITIES  OF ESCROW AGENT. It is
understood and agreed that the duties of the Escrow Agent are purely ministerial
in nature, and that:

          5.1  The Escrow Agent shall notify the Placement Agent, on a daily
basis, of the Escrow Amounts which have been deposited in the Bank Account and
of the amounts, constituting the Fund, which have cleared the banking system and
have been collected by the Escrow Agent.

          5.2  The Escrow Agent shall not be responsible for or be required to
enforce any of the terms or conditions of the selling agreement or any other
agreement between the Placement Agent and the Issuer nor shall the Escrow Agent
be responsible for the performance by the Placement Agent or the Issuer of their
respective obligations under this Agreement.

          5.3  The Escrow Agent shall not be required to accept from the
Placement Agent (or the Issuer) any Subscription Information pertaining to
prospective purchasers unless such Subscription Information is accompanied by
checks or wire transfers meeting the requirements of Section 3.1, nor shall the
Escrow Agent be required to keep records of any information with respect to
payments deposited by the Placement Agent (or the Issuer) except as to the
amount of such payments; however, the Escrow Agent shall notify the Placement
Agent within a reasonable time of any discrepancy between the amount set forth
in any Subscription Information and the amount delivered to the Escrow Agent
therewith. Such amount need not be accepted for deposit in the Escrow Account
until such discrepancy has been resolved.

          5.4  The Escrow Agent shall be under no duty or responsibility to
enforce collection of any check delivered to it hereunder. The Escrow Agent,
within a reasonable time, shall return to the Placement Agent any check received
which is dishonored, together with the Subscription Information, if any, which
accompanied such check.

          5.5  The Escrow Agent shall be entitled to rely upon the accuracy, act
in reliance upon the contents, and assume the genuineness of any notice,
instruction, certificate, signature, instrument or other document which is given
to the Escrow Agent pursuant to this Agreement without the necessity of the
Escrow Agent verifying the truth or accuracy thereof. The Escrow Agent shall not
be obligated to make any inquiry as to the authority, capacity, existence or
identity of any person purporting to give any such notice or instructions or to
execute any such certificate, instrument or other document.

          5.6  If the Escrow Agent is uncertain as to its duties or rights
hereunder or shall receive instructions with respect to the Bank Account, the
Escrow Amounts or the Fund which, in its sole determination, are in conflict
either with other instructions received by it or with any provision of this
Agreement, it shall be entitled to hold the Escrow Amounts, the Fund, or a
portion thereof, in the Bank Account pending the resolution of such uncertainty
to the Escrow

<Page>

Agent's sole satisfaction, by final judgment of a court or courts of competent
jurisdiction or otherwise.

          5.7  The Escrow Agent shall not be liable for any action taken or
omitted hereunder, or for the misconduct of any employee, agent or attorney
appointed by it, except in the case of willful misconduct or gross negligence.
The Escrow Agent shall be entitled to consult with counsel of its own choosing
and shall not be liable for any action taken, suffered or omitted by it in
accordance with the advice of such counsel.

          5.8  The Escrow Agent shall have no responsibility at any time to
ascertain whether or not any security interest exists in the Escrow Amounts, the
Fund or any part thereof or to file any financing statement under the Uniform
Commercial Code with respect to the Fund or any part thereof.

     6.   AMENDMENT; RESIGNATION OR REMOVAL OF ESCROW AGENT. This Agreement may
be altered or amended only with the written consent of the Issuer, the Placement
Agent and the Escrow Agent. The Escrow Agent may resign and be discharged from
its duties hereunder at any time by giving written notice of such resignation to
the Issuer and the Placement Agent specifying a date when such resignation shall
take effect and upon delivery of the Fund to the successor escrow agent
designated by the Issuer or the Placement Agent in writing. Such successor
Escrow Agent shall become the Escrow Agent hereunder upon the resignation date
specified in such notice. If the Company fails to designate a successor Escrow
Agent within thirty (30) days after such notice, then the resigning Escrow Agent
shall promptly refund the amount in the Fund to each prospective purchaser,
without interest thereon or deduction. The Escrow Agent shall continue to serve
until its successor accepts the escrow and receives the Fund. The Company shall
have the right at any time to remove the Escrow Agent and substitute a new
escrow agent by giving notice thereof to the Escrow Agent then acting. Upon its
resignation and delivery of the Fund as set forth in this Section 6, the Escrow
Agent shall be discharged of and from any and all further obligations arising in
connection with the escrow contemplated by this Agreement. Without limiting the
provisions of Section 8 hereof, the resigning Escrow Agent shall be entitled to
be reimbursed by the Issuer and the Placement Agent for any expenses incurred in
connection with its resignation, transfer of the Fund to a successor escrow
agent or distribution of the Fund pursuant to this Section 6.

     7.   REPRESENTATIONS AND WARRANTIES. The Issuer and the Placement Agent
hereby severally represent and warrant to the Escrow Agent that:

          7.1  No party other than the parties hereto and the prospective
purchasers have, or shall have, any lien, claim or security interest in the
Escrow Amounts or the Fund or any part thereof.

          7.2  No financing statement under the Uniform Commercial Code is on
file in any jurisdiction claiming a security interest in or describing (whether
specifically or generally) the Escrow Amounts or the Fund or any part thereof.

          7.3  The Subscription Information submitted with each deposit shall,
at the time of submission and at the time of the disbursement of the Fund, be
deemed a representation

<Page>

and warranty that such deposit represents a bona fide payment by the purchaser
described therein for the amount of Securities set forth in such Subscription
Information.

          7.4  Reasonable controls have been established and required due
diligence performed to comply with "Know Your Customer" regulations, USA Patriot
Act, Office of Foreign Asset Control (OFAC) regulations and the Bank Secrecy
Act.

     8.   FEES AND EXPENSES. The Escrow Agent shall be entitled to the Escrow
Agent Fees set forth below, payable upon the release of the Funds. In addition,
the Issuer and the Placement Agent jointly and severally agree to reimburse the
Escrow Agent for any reasonable expenses incurred in connection with this
Agreement, including, but not limited to, reasonable counsel fees. The Escrow
Agent Fees for the first closing shall be $1,000. All subsequent closings shall
be $500.

     9.   INDEMNIFICATION AND CONTRIBUTION.

          9.1  The Issuer and the Placement Agent (collectively referred to as
the "INDEMNITORS") jointly and severally agree to indemnify the Escrow Agent and
its partners, employees and agents (collectively referred to as the
"INDEMNITEES") against, and hold them harmless of and from, as and when
incurred, any and all loss, liability, cost, damage and expense, including
without limitation, reasonable counsel fees, which the Indemnitees may suffer or
incur by reason of any action, claim or proceeding brought against the
Indemnitees arising out of or relating in any way to this Agreement or any
transaction to which this Agreement relates, unless such action, claim or
proceeding is the result of the willful misconduct or gross negligence of the
Indemnitees.

          9.2  If the indemnification provided for in Section 9.1 is applicable,
but for any reason is held to be unavailable, the Indemnitors shall contribute
such amounts as are just and equitable to pay, or to reimburse the Indemnitees
for, the aggregate of any and all losses, liabilities, costs, damages and
expenses, including counsel fees, actually incurred by the Indemnitees as a
result of or in connection with, and any amount paid in settlement of, any
action, claim or proceeding arising out of or relating in any way to any actions
or omissions of the Indemnitors.

          9.3  The provisions of this Article 9 shall survive any termination of
this Agreement, whether by disbursement of the Fund, resignation of the Escrow
Agent or otherwise, for a period of 3 years from the release of the Fund.

     10.  TERMINATION OF AGREEMENT. This Agreement shall terminate on the final
disposition of the Fund pursuant to Section 4, provided that the rights of the
Escrow Agent and the obligations of the other parties hereto under Section 9
shall survive the termination hereof and the resignation or removal of the
Escrow Agent for a period of 3 years thereafter. The Termination Date shall be
July 1, 2005.

     11.  GOVERNING LAW AND ASSIGNMENT. This Agreement shall be construed in
accordance with and governed by the laws of the State of New York, without
regard to the

<Page>

conflicts of laws principles thereof, and shall be binding, upon the parties
hereto and their respective successors and assigns; PROVIDED, HOWEVER, that any
assignment or transfer by any party of its rights under this Agreement or with
respect to the Escrow Amounts or the Fund shall be void as against the Escrow
Agent unless (a) written notice thereof shall be given to the Escrow Agent; and
(b) the Escrow Agent shall have consented in writing to such assignment or
transfer.

     12.  NOTICES. All notices required to be given in connection with this
Agreement shall be sent by registered or certified mail, return receipt
requested, or by hand delivery with receipt acknowledged, or by the Express Mail
service offered by the United States Postal Service, and addressed, if to the
Issuer or the Placement Agent, at their respective addresses set forth below,
and if to the Escrow Agent, at its address set forth above.

     13.  SEVERABILITY. If any provision of this Agreement or the application
thereof to any person or circumstance shall be determined to be invalid or
unenforceable, the remaining provisions of this Agreement or the application of
such provision to persons or circumstances other than those to which it is held
invalid or unenforceable shall not be affected thereby and shall be valid and
enforceable to the fullest extent permitted by law.

     14.  EXECUTION IN SEVERAL COUNTERPARTS. This Agreement may be executed in
several counterparts or by separate instruments and by facsimile transmission,
and all of such counterparts and instruments shall constitute one agreement,
binding on all of the parties hereto.

     15.  NO CONFLICT. The Issuer acknowledges that the Escrow Agreement is
acting as counsel for the Placement Agent and that it agrees that such fact
shall not preclude Escrow Agreement from acting as counsel for Placement Agent
in any matters.

     16.  ENTIRE AGREEMENT. This Agreement constitutes the entire agreement
between the parties hereto with respect to the subject matter hereof and
supersedes all prior agreements and understandings (written or oral) of the
parties in connection therewith.

<Page>

          IN WITNESS WHEREOF, the undersigned have executed this Agreement as of
the day and year first above written.

                                   THELEN REID & PRIEST LLP,
                                   AS ESCROW AGENT

                                   By: /s/ Robert S. Matlin
                                       -------------------------------
                                       Name: Robert S. Matlin
                                       Title: Partner

                                   ISSUER: BIO-KEY INTERNATIONAL, INC.

                                   By: /s/ Thomas J. Colatosti
                                       -------------------------------
                                       Name: Thomas J. Colatosti
                                       Title: Chairman of the Board
                                       Address: 1285 Corporate Center Drive
                                                Suite 175
                                                Eagan, MN 55121

                                   PLACEMENT AGENT: JESUP & LAMONT SECURITIES
                                                     CORP.

                                   By: /s/ Douglass Bermingham
                                       -------------------------------
                                       Name: Douglass Bermingham
                                       Title: Managing Director
                                       Address: 650 Fifth Avenue
                                                New York, NY 10019Exhibit 10.6

 

EXECUTIVE SEVERANCE BENEFITS AGREEMENT

 

This EXECUTIVE SEVERANCE BENEFITS
AGREEMENT (the “Agreement”)
is entered into this 4th day of August, 2005 (the “Effective Date”), between
DANIEL N. SWISHER, JR. (“Executive”)
and SUNESIS PHARMACEUTICALS, INC.
(the “Company”). This Agreement is
intended to provide Executive with the compensation and benefits described
herein upon the occurrence of specific events. 
Certain capitalized terms used in this Agreement are defined in Article 6.

 

The Company and Executive hereby agree as follows:

 

ARTICLE 1

 

SCOPE OF AND CONSIDERATION FOR THIS AGREEMENT

 

1.1          Position and Duties.  Executive is currently employed by the
Company as Chief Executive Officer. 
Executive reports directly to the Board.

 

1.2          Restrictions.  During his employment by the Company,
Executive agrees to the best of his ability and experience that he will at all
times loyally and conscientiously perform all of the duties and obligations
required of and from him as Chief Executive Officer.  During the term of his employment, Executive
further agrees that he will devote all of his business time and attention to
the business of the Company, the Company will be entitled to all of the
benefits and profits arising from or incident to all such work, services and
advice, Executive will not render commercial or professional services of any
nature to any person or organization, whether or not for compensation, without
the prior written consent of the Board, and Executive will not directly or
indirectly engage or participate in any business that is competitive in any
manner with the business of the Company. 
Nothing in this Agreement will prevent Executive from accepting speaking
or presentation engagements in exchange for honoraria or from service on boards
of charitable organizations or otherwise participating in civic, charitable or
fraternal organizations, or from owning no more than one percent (1%) of the
outstanding equity securities of a corporation whose stock is listed on a
national stock exchange.  It is
contemplated that you may serve on a board of directors of other,
non-competitive companies, and the Sunesis Board of Directors will not
unreasonably withhold its consent from such participation.  Such participation shall not exceed the
greater of six (6) days per year or such number of days as is required for
you to serve on the board of directors of one such company.

 

1.3          Confidential
Information and Invention Assignment Agreement.  Executive acknowledges that he has previously
executed and delivered to an officer of the Company the Company’s Confidential
Information and Invention Assignment Agreement (the “Confidentiality  Agreement”)
and that the Confidentiality Agreement remains in full force and effect.

 

1.4          Confidentiality
of Terms.  Executive agrees to follow
the Company’s strict policy that employees must not disclose, either directly
or indirectly, any information, including any of the terms of this Agreement,
regarding salary, bonuses, or stock purchase or option 

 

 

allocations to any person, including other
employees of the Company; provided,
however, that Executive may
discuss such terms with members of his immediate family and any legal, tax or
accounting specialists who provide Executive with individual legal, tax or
accounting advice, and Executive may discuss such terms with other employees of
the Company on a need to know basis if required to carry out Executive’s duties
as the Chief Executive Officer or at the request of the Board.

 

1.5          Benefits Upon Change of Control.  The Company and Executive wish to set
forth the compensation and benefits which Executive shall be entitled to
receive in the event of a Change of Control or if Executive’s employment with
the Company is terminated under the circumstances described herein.

 

1.6          Consideration.  The duties and obligations of the Company to
Executive under this Agreement shall be in consideration for Executive’s past
services to the Company, Executive’s continued employment with the Company, and
Executive’s execution of a release in accordance with Section 4.1.

 

1.7          Prior Agreement.  This Agreement shall supersede any other
agreement relating to severance benefits in the event of Executive’s severance
from employment, including, without limitation the Employment Agreements
between Executive and the Company dated as of December 1, 2003 and December 3,
2001.

 

ARTICLE 2

 

OPTION ACCELERATION

 

2.1          Change of Control  Option Acceleration. 
In the event of a Change of Control, the vesting and/or
exercisability of fifty percent (50%) of Executive’s outstanding Stock Awards
shall be automatically accelerated immediately prior to the effective date of
such Change of Control.

 

2.2          Constructive
Termination Option Acceleration.

 

(a)           In
the event of a Covered Termination of Executive’s employment prior to or more
than twelve (12) months following the effective date of a Change of Control,
the vesting and/or exercisability of each of Executive’s outstanding Stock
Awards shall be automatically accelerated on the date of termination as to the
number of Stock Awards that would vest over the twelve (12) month period
following the date of termination had Executive remained continuously employed
by the Company during such period.

 

(b)           In
the event of a Covered Termination of Executive’s employment within twelve (12)
months following the effective date of a Change of Control, the vesting and/or
exercisability of one hundred percent (100%) of Executive’s outstanding Stock
Awards shall be automatically accelerated on the date of termination.

 

2.3          Outstanding Stock Awards.  For the avoidance of doubt, the fifty percent
(50%), twelve (12) month and one hundred percent (100%) accelerated vesting
described in Sections 2.1 

 

2

 

and 2.2 shall apply toward that portion of
Executive’s outstanding Stock Awards that are unvested as of the date of
accelerated vesting.

 

ARTICLE 3

 

SEVERANCE BENEFITS

 

3.1          Severance Benefits.  A Covered Termination of Executive’s
employment prior to or more than twelve (12) months following the effective date
of a Change of Control entitles Executive to receive the benefits set forth in
this Section 3.1.

 

(a)           Base Salary.  The Company shall pay to Executive an amount
equal to twelve (12) months’ Base Salary. 
Such severance amount shall be paid over
the twelve (12) month period commencing on the date of termination in equal
monthly installments and shall be subject to all required tax withholding.

 

(b)           Health Benefits.  Provided that Executive elects continued
coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as
amended (“COBRA”), the Company
shall pay the premiums of Executive’s group health insurance coverage,
including coverage for Executive’s eligible dependents, for a maximum period of
twelve (12) months following such Covered Termination; provided, however, that the Company shall
pay premiums for Executive’s eligible dependents only for coverage for which
those eligible dependents were enrolled immediately prior to the Covered
Termination.  It being understood that it
shall be Executive’s sole responsibility to elect continuation of coverage
pursuant to COBRA in the first instance. 
No premium payments will be made following the effective date of
Executive’s coverage by a health insurance plan of a subsequent employer.  For the balance of the period that Executive
is entitled to coverage under federal COBRA law, if any, Executive shall be
entitled to maintain such coverage at Executive’s own expense.

 

3.2          Change of Control Severance Benefits.  A Covered Termination of Executive’s employment
within twelve (12) months following the effective date of a Change of Control
entitles Executive to receive the benefits set forth in this Section 3.2.

 

(a)           Base Salary.  The Company shall pay to Executive an amount
equal to eighteen (18) months’ Base Salary. 
Such severance amount shall be paid in cash in a lump sum within thirty
(30) days following the Covered Termination and shall be subject to all
required tax withholding.

 

(b)           Bonus. 
The Company shall pay to Executive an amount equal to eighteen twelfths
(18/12ths) of Executive’s target annual bonus for the fiscal year during which
the Covered Termination occurs, with such bonus determined assuming that all of
the performance objectives for such fiscal year have been attained.  Such severance amount shall be paid in cash
in a lump sum within thirty (30) days following the Covered Termination and
shall be subject to all required tax withholding.

 

(c)           Health Benefits.  Provided that Executive elects continued
coverage under federal COBRA law, the Company shall pay the premiums of
Executive’s group health insurance coverage, including coverage for Executive’s
eligible dependents, for a maximum 

 

3

 

period of eighteen (18) months
following such Covered Termination; provided,
however, that the Company shall pay premiums for Executive’s
eligible dependents only for coverage for which those eligible dependents were
enrolled immediately prior to the Covered Termination.  It being understood that it shall be
Executive’s sole responsibility to elect continuation of coverage pursuant to
COBRA in the first instance.  No premium
payments will be made following the effective date of Executive’s coverage by a
health insurance plan of a subsequent employer. 
For the balance of the period that Executive is entitled to coverage
under federal COBRA law, if any, Executive shall be entitled to maintain such
coverage at Executive’s own expense.

 

(d)           No
Duplication of Benefits.  The
payments and benefits provided for in this Section 3.2 shall only be
payable in the event of a Covered Termination of Executive’s employment within
twelve (12) months following the effective date of a Change of Control.  In the event of a Covered Termination of
Executive’s employment prior to or more than twelve (12) months following a
Change Control, then Executive shall receive the payments and benefits
described in Section 3.1 and shall not be eligible to receive any of the
payments and benefits described in this Section 3.2.

 

3.3          Other Terminations.  If Executive’s employment is terminated by
the Company for Cause, by Executive other than pursuant to a Constructive
Termination or as a result of Executive’s death or disability, the Company
shall not have any other or further obligations to Executive under this
Agreement (including any financial obligations) except that Executive shall be
entitled to receive (a) Executive’s fully earned but unpaid base salary,
through the date of termination at the rate then in effect, and (b) all
other amounts or benefits to which Executive is entitled under any
compensation, retirement or benefit plan or practice of the Company at the time
of termination in accordance with the terms of such plans or practices,
including, without limitation, any continuation of benefits required by federal
COBRA law or applicable law.  In
addition, subject to the provisions of the Company’s equity compensation plans
and the terms of Executive’s Stock Awards, if Executive’s employment is
terminated by the Company for Cause, by Executive other than pursuant to a
Constructive Termination or as a result of Executive’s death or disability, all
vesting of Executive’s unvested Stock Awards previously granted to him by the
Company shall cease and none of such unvested Stock Awards shall be exercisable
following the date of such termination. 
The foregoing shall be in addition to, and not in lieu of, any and all
other rights and remedies which may be available to the Company under the
circumstances, whether at law or in equity.

 

3.4          Mitigation.  Except as otherwise specifically provided
herein, Executive shall not be required to mitigate damages or the amount of
any payment provided under this Agreement by seeking other employment or
otherwise, nor shall the amount of any payment provided for under this
Agreement be reduced by any compensation earned by Executive as a result of
employment by another employer or by any retirement benefits received by
Executive after the date of the Covered Termination.

 

3.5          Exclusive
Remedy.  Except as otherwise
expressly required by law (e.g., COBRA) or as specifically provided herein, all
of Executive’s rights to salary, severance, benefits, bonuses and other amounts
hereunder (if any) accruing after the termination of Executive’s employment
shall cease upon such termination.  In
the event of a termination of 

 

4

 

Executive’s employment with the Company,
Executive’s sole remedy shall be to receive the payments and benefits described
in this Agreement.

 

ARTICLE 4

 

LIMITATIONS AND CONDITIONS ON BENEFITS

 

4.1          Release Prior to Payment of Benefits.  Upon the occurrence of a Covered Termination
of Executive’s employment, and prior to the payment of any benefits under this
Agreement on account of such Covered Termination, Executive shall execute a
release (the “Release”) in the
form attached hereto and incorporated herein as Exhibit A or Exhibit B,
as applicable.  Such Release shall
specifically relate to all of Executive’s rights and claims in existence at the
time of such execution and shall confirm Executive’s obligations under the
Confidentiality Agreement.  It is
understood that, as specified in the applicable Release, Executive has a
certain number of calendar days to consider whether to execute such Release,
and Executive may revoke such Release within seven (7) calendar days after
execution.  In the event Executive does
not execute such Release within the applicable period, or if Executive revokes
such Release within the subsequent seven (7) day period, no benefits shall
be payable under this Agreement.

 

4.2          Termination of Benefits.  Benefits under this Agreement shall terminate
immediately if the Executive, at any time, violates any proprietary information
or confidentiality obligation to the Company, including, without limitation,
the Confidentiality Agreement.

 

ARTICLE 5

 

PARACHUTE PAYMENTS

 

5.1          Best Pay Provision.  Anything in this Agreement to the
contrary notwithstanding, in the event it shall be determined that any Payment
under this Agreement would, when combined with all other Payments Executive
receives from the Company or any successor or parent or subsidiary thereof, but
for this Article 5, be subject to the Excise Tax, then such Payments shall
be either (a) the full amount of such Payments or (b) such lesser
amount (with cash payments being reduced before stock option compensation) as
would result in no portion of the Payments being subject to the Excise Tax,
whichever of the foregoing amounts, taking into account the applicable federal,
state and local employment taxes, income taxes and the Excise Tax, results in
Executive’s receipt, on an after-tax basis, of the greater amount of the
Payments notwithstanding that all or some portion of the Payments may be
subject to the Excise Tax.

 

5.2          Determinations.  All determinations required to be made
under this Article 5, including whether and to what extent the Payments
shall be reduced and the assumptions to be utilized in arriving at such
determination, shall be made by the nationally recognized certified public accounting
firm used by the Company immediately prior to the Change of Control or, if such
firm declines to serve, such other nationally recognized certified public
accounting firm as may be designated by the Executive (the “Accounting Firm”).  The Accounting Firm shall provide detailed
supporting calculations both to the Company and the Executive at such time as
is requested by the Company.  All fees
and expenses of the Accounting Firm shall be borne 

 

5

 

solely by the Company.  Any determination by the Accounting Firm
shall be binding upon the Company and the Executive.  For purposes of making the calculations
required by this Article 5, the Accounting Firm may make reasonable
assumptions and approximations concerning applicable taxes and may rely on
reasonable, good-faith interpretations concerning the application of Sections
280G and 4999 of the Code.

 

ARTICLE 6

 

DEFINITIONS

 

For purposes of the Agreement, the following terms are defined as
follows:

 

6.1          “Base Salary” means Executive’s annual
base salary as in effect during the last regularly scheduled payroll period
immediately preceding the Covered Termination.

 

6.2          “Board” means the Board of Directors of
the Company.

 

6.3          “Cause” means that, in the reasonable
determination of the Company, Executive:

 

(a)           has committed an act of fraud or
embezzlement or has intentionally committed some other illegal act that has a
material adverse impact on the Company or any successor or parent or subsidiary
thereof;

 

(b)           has been convicted of, or entered a plea
of “guilty” or “no contest” to, a felony which causes or may reasonably be
expected to cause substantial economic injury to or substantial injury to the
reputation of the Company or any subsidiary or affiliate of the Company;

 

(c)           has made any unauthorized use or
disclosure of confidential information or trade secrets of the Company or any
successor or parent or subsidiary thereof that has a material adverse impact on
any such entity;

 

(d)           has committed any other intentional
misconduct that has a material adverse impact on the Company or any successor
or parent or subsidiary thereof, or

 

(e)           has intentionally refused or
intentionally failed to act in accordance with any lawful and proper direction
or order of the Board; provided such direction is not materially inconsistent
with the Executive’s customary duties and responsibilities.

 

6.4          “Change of Control” means and includes
each of the following:

 

(a)           the
acquisition, directly or indirectly, by any “person” or “group” (as those terms
are defined in Sections 3(a)(9), 13(d) and 14(d) of the Securities
Exchange Act of 1934, as amended, and the rules thereunder) of “beneficial
ownership” (as determined pursuant to Rule 13d-3 under the Securities
Exchange Act of 1934, as amended) of securities entitled to vote generally in
the election of directors (“voting securities”)
of the Company that represent fifty percent (50%) or more of the combined
voting power of the Company’s then outstanding voting securities, other than:

 

6

 

(i)            an
acquisition by a trustee or other fiduciary holding securities under any
employee benefit plan (or related trust) sponsored or maintained by the Company
or any person controlled by the Company or by any employee benefit plan (or
related trust) sponsored or maintained by the Company or any person controlled
by the Company, or

 

(ii)           an acquisition of voting securities by
the Company or a corporation owned, directly or indirectly by the stockholders
of the Company in substantially the same proportions as their ownership of the
stock of the Company;

 

Notwithstanding
the foregoing, the following event shall not constitute an “acquisition” by any
person or group for purposes of this Section: an acquisition of the Company’s
securities by the Company that causes the Company’s voting securities
beneficially owned by a person or group to represent fifty percent (50%) or
more of the combined voting power of the Company’s then outstanding voting
securities; provided, however,
that if a person or group shall become the beneficial owner of fifty percent
(50%) or more of the combined voting power of the Company’s then outstanding
voting securities by reason of share acquisitions by the Company as described
above and shall, after such share acquisitions by the Company, become the
beneficial owner of any additional voting securities of the Company, then such
acquisition shall constitute a Change of Control; or

 

(b)           the
consummation by the Company (whether directly involving the Company or
indirectly involving the Company through one or more intermediaries) of
(x) a merger, consolidation, reorganization, or business combination or
(y) a sale or other disposition of all or substantially all of the Company’s
assets or (z) the acquisition of assets or stock of another entity, in
each case other than a transaction:

 

(i)            which
results in the Company’s voting securities outstanding immediately before the
transaction continuing to represent (either by remaining outstanding or by
being converted into voting securities of the Company or the person that, as a
result of the transaction, controls, directly or indirectly, the Company or
owns, directly or indirectly, all or substantially all of the Company’s assets
or otherwise succeeds to the business of the Company (the Company or such
person, the “Successor Entity”))
directly or indirectly, at least a majority of the combined voting power of the
Successor Entity’s outstanding voting securities immediately after the
transaction, and

 

(ii)           after
which no person or group beneficially owns voting securities representing fifty
percent (50%) or more of the combined voting power of the Successor Entity; provided, however, that no person or group
shall be treated for purposes of this clause (ii) as beneficially
owning fifty percent (50%) or more of combined voting power of the Successor
Entity solely as a result of the voting power held in the Company prior to the
consummation of the transaction; or

 

(c)           the
Company’s stockholders approve a liquidation or dissolution of the Company.

 

Notwithstanding
the foregoing, a transaction shall not constitute a Change of Control if: (i) it
constitutes the Company’s initial public offering of its securities; or (ii) it
is a transaction 

 

7

 

effected primarily for the purpose of
financing the Company with cash (as determined by the Board in its discretion
and without regard to whether such transaction is effectuated by a merger,
equity financing or otherwise).  The Board
shall have full and final authority, which shall be exercised in its
discretion, to determine conclusively whether a Change of Control of the
Company has occurred pursuant to the above definition, and the date of the
occurrence of such Change of Control and any incidental matters relating
thereto.

 

6.5          “Code” means the Internal Revenue Code of
1986, as amended from time to time and the Treasury Regulations thereunder.

 

6.6          “Company” means Sunesis Pharmaceuticals, Inc.
or, following a Change of Control, the surviving entity resulting from such
transaction.

 

6.7          “Constructive Termination” means that
Executive voluntarily terminates employment after any of the following are
undertaken without Executive’s express written consent:

 

(a)           the removal of or a
material reduction in the nature or scope of Executive’s responsibilities, or
the assignment to Executive of duties that are materially inconsistent with
Executive’s position other than a change in reporting relationship;

 

(b)           a change in the
Executive’s direct reporting relationship so that Executive no longer reports
directly to the Board;

 

(c)           a
reduction in Executive’s base salary, unless the base salaries of all other
executives are similarly reduced;

 

(d)           a
reduction in Executive’s target bonus within twelve (12) months following the
effective date of a Change of Control, unless the target bonuses of all other
executives are similarly reduced; or

 

(e)           a relocation of
Executive’s place of employment by more than thirty (30) miles from such
Executive’s place of employment on the Effective Date.

 

The termination of Executive’s employment as a result of Executive’s
death or disability will not be deemed to be a Constructive Termination.

 

6.8          “Covered Termination” means an
Involuntary Termination Without Cause or a Constructive Termination.

 

6.9          “Excise
Tax” means the excise tax imposed by Section 4999 of the Code,
together with any interest or penalties imposed with respect to such excise
tax.

 

6.10        “Involuntary
Termination Without Cause” means Executive’s dismissal or discharge
other than for Cause.  The termination of
Executive’s employment as a result of Executive’s death or disability will not
be deemed to be an Involuntary Termination Without Cause.

 

8

 

6.11        A “Payment”
shall mean any payment or distribution in the nature of compensation (within
the meaning of Section 280G(b)(2) of the Code) to or for the benefit
of the Executive, whether paid or payable pursuant to this Agreement or
otherwise.

 

6.12        “Stock Awards” means all stock options,
restricted stock and such other awards granted pursuant to the Company’s stock
option and equity incentive award plans or agreements and any shares of stock
issued upon exercise thereof.

 

ARTICLE 7

 

GENERAL PROVISIONS

 

7.1          Employment Status.  This Agreement does not constitute a contract
of employment or impose upon Executive any obligation to remain as an employee,
or impose on the Company any obligation (a) to retain Executive as an
employee, (b) to change the status of Executive as an at-will employee, or
(c) to change the Company’s policies regarding termination of employment.

 

7.2          Notices. 
Any notices provided hereunder must be in writing, and such notices or
any other written communication shall be deemed effective upon the earlier of
personal delivery (including personal delivery by facsimile) or the third day
after mailing by first class mail to the Company at its primary office location
and to Executive at Executive’s address as listed in the Company’s payroll
records.  Any payments made by the
Company to Executive under the terms of this Agreement shall be delivered to
Executive either in person or at the address as listed in the Company’s payroll
records.

 

7.3          Severability.  Whenever possible, each provision of this Agreement
will be interpreted in such manner as to be effective and valid under
applicable law, but if any provision of this Agreement is held to be invalid,
illegal or unenforceable in any respect under any applicable law or rule in
any jurisdiction, such invalidity, illegality or unenforceability will not
affect any other provision or any other jurisdiction, but this Agreement will
be reformed, construed and enforced in such jurisdiction as if such invalid,
illegal or unenforceable provisions had never been contained herein.

 

7.4          Waiver. 
If either party should waive any breach of any provisions of this
Agreement, he or it shall not thereby be deemed to have waived any preceding or
succeeding breach of the same or any other provision of this Agreement.

 

7.5          Arbitration.  Any dispute, claim or controversy based on,
arising out of or relating to Executive’s employment or this Agreement shall be
settled by final and binding arbitration in San Mateo County, California,
before a single neutral arbitrator in accordance with the National Rules for
the Resolution of Employment Disputes (the “Rules”)
of the American Arbitration Association, and judgment on the award rendered by
the arbitrator may be entered in any court having jurisdiction.  Arbitration may be compelled pursuant to the
California Arbitration Act (Code of Civil Procedure §§ 1280 et  seq.).  If the parties are unable to agree upon an
arbitrator, one shall be appointed by the AAA in accordance with its
Rules.  Each party shall pay the fees of
its own attorneys, the expenses of its witnesses and all other expenses
connected 

 

9

 

with presenting its case; however, Executive and the Company agree
that, to the extent permitted by law, the arbitrator may, in his discretion,
award reasonable attorneys’ fees to the prevailing party.  Other costs of the arbitration, including the
cost of any record or transcripts of the arbitration, AAA’s administrative
fees, the fee of the arbitrator, and all other fees and costs, shall be borne
by the Company.  This Section 7.5 is
intended to be the exclusive method for resolving any and all claims by the
parties against each other for payment of damages under this Agreement or
relating to Executive’s employment; provided,
however, that neither this
Agreement nor the submission to arbitration shall limit the parties’ right to
seek provisional relief, including, without limitation, injunctive relief, in
any court of competent jurisdiction pursuant to California Code of Civil
Procedure § 1281.8 or any similar statute of an applicable
jurisdiction.  Seeking any such relief
shall not be deemed to be a waiver of such party’s right to compel
arbitration.  Both Executive and the
Company expressly waive their right to a jury trial. Pursuant to California
Civil Code Section 1717, each party warrants that it was represented by
counsel in the negotiation and execution of this Agreement, including the
attorneys’ fees provision herein.

 

7.6          Complete Agreement.  This Agreement, including Exhibit A and Exhibit B,
constitutes the entire agreement between Executive and the Company and is the
complete, final, and exclusive embodiment of their agreement with regard to
this subject matter, wholly superseding all written and oral agreements with
respect to severance benefits to Executive in the event of employment
termination.  It is entered into without
reliance on any promise or representation other than those expressly contained
herein.  Notwithstanding anything herein
to the contrary, this Agreement shall not supersede any indemnification
agreement between Executive and the Company.

 

7.7          Amendment or Termination of Agreement.  This Agreement may be changed or terminated
only upon the mutual written consent of the Company and Executive.  The written consent of the Company to a
change or termination of this Agreement must be signed by an executive officer
of the Company after such change or termination has been approved by the Board.

 

7.8          Counterparts.  This Agreement may be executed in separate
counterparts, any one of which need not contain signatures of more than one
party, but all of which taken together will constitute one and the same
Agreement.

 

7.9          Headings. 
The headings of the Articles and Sections hereof are inserted for
convenience only and shall not be deemed to constitute a part hereof nor to
affect the meaning thereof.

 

7.10        Successors and Assigns.  This Agreement is intended to bind and inure
to the benefit of and be enforceable by Executive, and the Company, and any
surviving entity resulting from a Change of Control and upon any other person
who is a successor by merger, acquisition, consolidation or otherwise to the
business formerly carried on by the Company, and their respective successors,
assigns, heirs, executors and administrators, without regard to whether or not
such person actively assumes any rights or duties hereunder; provided, however, that Executive may not
assign any duties hereunder and may not assign any rights hereunder without the
written consent of the Company, which consent shall not be withheld
unreasonably.

 

10

 

7.11        Choice of Law.  All questions concerning the construction,
validity and interpretation of this Agreement will be governed by the law of
the State of California, without regard to such state’s conflict of laws rules.

 

7.12        Non-Publication.  The parties mutually agree not to disclose
publicly the terms of this Agreement except to the extent that disclosure is
mandated by applicable law or regulation or to their respective advisors (e.g., attorneys, accountants).

 

7.13        Construction of Agreement.  In the event of a conflict between the text
of the Agreement and any summary, description or other information regarding
the Agreement, the text of the Agreement shall control.

 

7.14        Code
Section 409A.  This Agreement
shall be interpreted, construed and administered in a manner that satisfies the
requirements of Sections 409A of the Code, and any payment scheduled to be made
hereunder that would otherwise violate Section 409A of the Code shall be
delayed to the extent necessary for this Agreement and such payment to comply
with Section 409A of the Code.

 

(Signature Page Follows)

 

11

 

IN
WITNESS WHEREOF, the parties have executed this
Agreement on the Effective Date written above.

 

 

	
  SUNESIS PHARMACEUTICALS, INC.

  	
  DANIEL N. SWISHER, JR.

  
	
   

  	
   

  
	
   

  	
   

  
	
  By:

  	
  /s/ Anthony
  B. Evnin

  	
   

  	
  /s/ Daniel
  N. Swisher, Jr.

  	
   

  
	
  Name:

  	
  Anthony B.
  Evnin

  	
   

  	
   

  
	
  Title:

  	
  Chairman of
  the Compensation

  	
   

  	
   

  
	
  Committee of
  the Board of Directors

  	
   

  	
   

  
							

 

 

Exhibit A:  Release (Individual Termination)

Exhibit B:  Release (Group Termination)

 

12

 

EXHIBIT A

 

RELEASE

(INDIVIDUAL TERMINATION)

 

Certain capitalized terms used in this Release are defined in the
Executive Severance Benefits Agreement (the “Agreement”)
which I have executed and of which this Release is a part.

 

I hereby confirm my obligations under the Company’s proprietary
information and inventions agreement.

 

I acknowledge that I have read and understand Section 1542 of the
California Civil Code which reads as follows: “A
general release does not extend to claims which the creditor does not know or
suspect to exist in his or her favor at the time of executing the release,
which if known by him or her must have materially affected his or her
settlement with the debtor.” 
I hereby expressly waive and relinquish all rights and benefits under
that section and any law of any jurisdiction of similar effect with
respect to my release of any claims I may have against the Company.

 

Except as otherwise set forth in this Release, I hereby release, acquit
and forever discharge the Company, its parents and subsidiaries, and their
officers, directors, agents, servants, employees, shareholders, successors,
assigns and affiliates, of and from any and all claims, liabilities, demands,
causes of action, costs, expenses, attorneys fees, damages, indemnities and
obligations of every kind and nature, in law, equity, or otherwise, known and
unknown, suspected and unsuspected, disclosed and undisclosed (other than any
claim for indemnification I may have as a result of any third party action
against me based on my employment with the Company), arising out of or in any
way related to agreements, events, acts or conduct at any time prior to the
date I execute this Release, including, but not limited to:  all such claims and demands directly or
indirectly arising out of or in any way connected with my employment with the
Company or the termination of that employment, including but not limited to,
claims of intentional and negligent infliction of emotional distress, any and
all tort claims for personal injury, claims or demands related to salary,
bonuses, commissions, stock, stock options, or any other ownership interests in
the Company, vacation pay, fringe benefits, expense reimbursements, severance
pay, or any other form of disputed compensation; claims pursuant to any
federal, state or local law or cause of action including, but not limited to,
the federal Civil Rights Act of 1964, as amended; the federal Age
Discrimination in Employment Act of 1967, as amended (“ADEA”); the federal Employee Retirement
Income Security Act of 1974, as amended; the federal Americans with
Disabilities Act of 1990; the California Fair Employment and Housing Act, as
amended; tort law; contract law; statutory law; common law; wrongful discharge;
discrimination; fraud; defamation; emotional distress; and breach of the
implied covenant of good faith and fair dealing; provided, however, that nothing in this paragraph shall be
construed in any way to release the Company from its obligation to indemnify me
pursuant to the Company’s indemnification obligation pursuant to agreement or
applicable law.

 

1

 

I acknowledge that I am knowingly and voluntarily waiving and releasing
any rights I may have under ADEA.  I also
acknowledge that the consideration given under the Agreement for the waiver and
release in the preceding paragraph hereof is in addition to anything of value
to which I was already entitled.  I
further acknowledge that I have been advised by this writing, as required by
the ADEA, that:  (A) my waiver and
release do not apply to any rights or claims that may arise on or after the
date I execute this Release; (B) I have the right to consult with an
attorney prior to executing this Release; (C) I have twenty-one (21) days
to consider this Release (although I may choose to voluntarily execute this
Release earlier); (D) I have seven (7) days following the execution
of this Release by the parties to revoke the Release; and (E) this Release
shall not be effective until the date upon which the revocation period has
expired, which shall be the eighth day after this Release is executed by me.

 

	
   

  	
  DANIEL N. SWISHER, JR.

  
	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  Date:

  	
   

  	
   

  
					

 

2

 

EXHIBIT B

 

RELEASE

(GROUP TERMINATION)

 

Certain capitalized terms used in this Release are defined in the
Executive Severance Benefits Agreement (the “Agreement”)
which I have executed and of which this Release is a part.

 

I hereby confirm my obligations under the Company’s proprietary
information and inventions agreement.

 

I acknowledge that I have read and understand Section 1542 of the
California Civil Code which reads as follows: “A
general release does not extend to claims which the creditor does not know or
suspect to exist in his or her favor at the time of executing the release,
which if known by him or her must have materially affected his or her
settlement with the debtor.” 
I hereby expressly waive and relinquish all rights and benefits under
that section and any law of any jurisdiction of similar effect with
respect to my release of any claims I may have against the Company.

 

Except as otherwise set forth in this Release, I hereby release, acquit
and forever discharge the Company, its parents and subsidiaries, and their
officers, directors, agents, servants, employees, shareholders, successors,
assigns and affiliates, of and from any and all claims, liabilities, demands,
causes of action, costs, expenses, attorneys fees, damages, indemnities and
obligations of every kind and nature, in law, equity, or otherwise, known and
unknown, suspected and unsuspected, disclosed and undisclosed (other than any
claim for indemnification I may have as a result of any third party action
against me based on my employment with the Company), arising out of or in any
way related to agreements, events, acts or conduct at any time prior to the
date I execute this Release, including, but not limited to:  all such claims and demands directly or
indirectly arising out of or in any way connected with my employment with the
Company or the termination of that employment, including but not limited to, claims
of intentional and negligent infliction of emotional distress, any and all tort
claims for personal injury, claims or demands related to salary, bonuses,
commissions, stock, stock options, or any other ownership interests in the
Company, vacation pay, fringe benefits, expense reimbursements, severance pay,
or any other form of disputed compensation; claims pursuant to any federal,
state or local law or cause of action including, but not limited to, the
federal Civil Rights Act of 1964, as amended; the federal Age Discrimination in
Employment Act of 1967, as amended (“ADEA”);
the federal Employee Retirement Income Security Act of 1974, as amended; the
federal Americans with Disabilities Act of 1990; the California Fair Employment
and Housing Act, as amended; tort law; contract law; statutory law; common law;
wrongful discharge; discrimination; fraud; defamation; emotional distress; and
breach of the implied covenant of good faith and fair dealing; provided, however, that nothing in this
paragraph shall be construed in any way to release the Company from its
obligation to indemnify me pursuant to the Company’s indemnification obligation
pursuant to agreement or applicable law.

 

1

 

I acknowledge that I am knowingly and voluntarily waiving and releasing
any rights I may have under ADEA.  I also
acknowledge that the consideration given under the Agreement for the waiver and
release in the preceding paragraph hereof is in addition to anything of value
to which I was already entitled.  I
further acknowledge that I have been advised by this writing, as required by
the ADEA, that:  (A) my waiver and
release do not apply to any rights or claims that may arise on or after the
date I execute this Release; (B) I have the right to consult with an
attorney prior to executing this Release; (C) I have forty-five (45) days
to consider this Release (although I may choose to voluntarily execute this
Release earlier); (D) I have seven (7) days following the execution
of this Release by the parties to revoke the Release; (E) this Release
shall not be effective until the date upon which the revocation period has
expired, which shall be the eighth day after this Release is executed by me;
and (F) I have received with this Release a detailed list of the job
titles and ages of all employees who were terminated in this group termination
and the ages of all employees of the Company in the same job classification or
organizational unit who were not terminated.

 

	
   

  	
  DANIEL N. SWISHER, JR.

  
	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  Date:

  	
   

  	
   

  
				

 

2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00090-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00090-of-00352.parquet"}]]